Bisphosphonates for the relief of pain secondary to bone metastases

Secondary title: 
T2 - Cochrane Database of Systematic Reviews
Short title: 
Bisphosphonates for the relief of pain secondary to bone metastases
Authors: 
Wong, R. K. S.
Wiffen, P. J.
Volume: 
(4)
Annotations: 
Type A, Priority 5
Year: 
2009
Accession number: 
2010192878
Database: 
EMBASE SR
Number: 
M1 - CD002068
Serial: 
1469-493X
Type of work: 
M3 - Review
ID: 
11619
DOI: 
http://dx.doi.org/10.1002/14651858.CD002068
Key words: 
abdominal pain/si [Side Effect]
allergic reaction/si [Side Effect]
anorexia/si [Side Effect]
bleeding/si [Side Effect]
bone metastasis/co [Complication]
bone pain/co [Complication]
bone pain/dm [Disease Management]
bone pain/dt [Drug Therapy]
breast cancer
clinical trial
constipation/si [Side Effect]
diarrhea/si [Side Effect]
drug dose comparison
drug effect
drug efficacy
drug use
drug withdrawal
dysphagia/si [Side Effect]
dyspnea/si [Side Effect]
esophagus ulcer/si [Side Effect]
fatigue/si [Side Effect]
fever/si [Side Effect]
gastrointestinal hemorrhage/si [Side Effect]
gastrointestinal symptom/si [Side Effect]
headache/si [Side Effect]
heart arrhythmia/si [Side Effect]
heart failure/si [Side Effect]
human
hypocalcemia/si [Side Effect]
infection/si [Side Effect]
lung cancer
morning dosage
multiple myeloma/dt [Drug Therapy]
musculoskeletal pain/si [Side Effect]
myalgia/si [Side Effect]
nausea/si [Side Effect]
pain/si [Side Effect]
pain assessment
prostate cancer
quality of life
review
rigor/si [Side Effect]
skin allergy/si [Side Effect]
skin changes/si [Side Effect]
skin disease/si [Side Effect]
stomach ulcer/si [Side Effect]
systematic review
treatment outcome
vomiting/si [Side Effect]
weakness/si [Side Effect]
analgesic agent/dt [Drug Therapy]
clodronic acid/ae [Adverse Drug Reaction]
clodronic acid/ct [Clinical Trial]
clodronic acid/dt [Drug Therapy]
clodronic acid/im [Intramuscular Drug Administration]
clodronic acid/iv [Intravenous Drug Administration]
clodronic acid/po [Oral Drug Administration]
codeine/dt [Drug Therapy]
etidronic acid/ae [Adverse Drug Reaction]
etidronic acid/ct [Clinical Trial]
etidronic acid/dt [Drug Therapy]
etidronic acid/im [Intramuscular Drug Administration]
etidronic acid/iv [Intravenous Drug Administration]
etidronic acid/po [Oral Drug Administration]
melphalan/cb [Drug Combination]
melphalan/dt [Drug Therapy]
morphine/dt [Drug Therapy]
pamidronic acid/ae [Adverse Drug Reaction]
pamidronic acid/ct [Clinical Trial]
pamidronic acid/do [Drug Dose]
pamidronic acid/dt [Drug Therapy]
pamidronic acid/iv [Intravenous Drug Administration]
pamidronic acid/po [Oral Drug Administration]
paracetamol/dt [Drug Therapy]
prednisone/cb [Drug Combination]
prednisone/dt [Drug Therapy]
Types of evidence: 
Type A
Priorities of Care: 
Priority 5: Plan and do